Home Latest News COVID-19 Vaccines 101: FAQ

COVID-19 Vaccines 101: FAQ

Rate this post

Paul Offit, MD, director, Vaccine Education Center, and professor of pediatrics, Children’s Hospital of Philadelphia; professor of vaccinology, Perelman School of Medicine, University of Pennsylvania.

CDC: “Vaccines: The Basics,” “When Vaccine is Limited, Who Gets Vaccinated First?” “Understanding How COVID-19 Vaccines Work,” “Meeting of the Advisory Committee on Immunization Practices (ACIP) November 23,” “Understanding mRNA COVID-19 Vaccines.”

JAMA: “COVID-19 and mRNA Vaccines — First Large Test for a New Approach.”

The Lancet: “Oxford-AstraZeneca COVID-19 vaccine efficacy.”

Facebook interview: Mark Zuckerberg and Anthony Fauci, MD, Nov. 30, 2020.

FDA: “Vaccines and Related Biological Products Advisory Committee Meeting, Dec. 17, 2020.”

Naor Bar-Zeev, PhD, associate professor of international health and vaccinology and deputy director, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore.

Statista.com: “The Cost Per Jab of Covid-19 Vaccine Candidates.”

AstraZeneca: “COVID-19 vaccine AZD1222 is better tolerated in older adults than younger adults with similar immune responses across all age groups.”

The Lancet: “Safety and immunogenicity of ChAdOx1nCoV-19 in a prime-boost regimen in young and old adults (COV002) in a single-blind, randomized, controlled, phase 2/3 trial.”

Moderna: “Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study.”

BMJ.com: “Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows.”

CBS News: “UK warns against giving Pfizer vaccine to people prone to severe allergic reactions.”


I would really love you to Leave a Reply and let me know what other content you would like from me. Thank You!

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Exit mobile version